To understand how Gdpd3 deficiency affects downstream signalling pathways, we first investigated the AKT/mTORC1 pathway in LT-CML stem cells isolated from Gdpd3+/+ and Gdpd3−/− tet-CML mice. Here, GDPD3 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.